Oren Ilan 4

What Happened

• Oren Ilan, a director of Roivant Sciences Ltd. (ROIV), received an award of 896 common shares under the company's Non‑Employee Director Compensation Plan that were fully vested as of the grant date (transaction code A). To cover tax withholding on the award, 95 of those shares were net‑settled (transaction code F) at $29.83 per share, resulting in a disposition value of $2,834.

Key Details

• Transaction date: 2026-04-17 (grant and net settlement).
• Award: 896 shares (acquired at $0.00 per Form 4 disclosure because they were awarded/vested).
• Tax withholding/net settlement: 95 shares disposed at $29.83 each — $2,834 total.
• Footnotes: F1 notes the award was fully vested at grant; F2 explains the 95‑share disposition was a net settlement by the issuer to satisfy tax withholding obligations.
• Shares owned after the transaction: not specified in the provided filing.
• Filing date: 2026-04-21 — filing appears to have been submitted within the normal Form 4 reporting window.

Context

• This was an equity award to a non-employee director that vested and was partially net‑settled to cover taxes. Net settlement for withholding is routine and does not necessarily indicate a buy or sell decision on the market.
• Transaction codes: A = award/grant; F = tax withholding/net settlement.